Evidence map›Paper›PMID 22908231›Full record

ArticleThe Journal of biological chemistry2012

Identification of a novel LXXLL motif in α-actinin 4-spliced isoform that is critical for its interaction with estrogen receptor α and co-activators.

Simran Khurana, Sharmistha Chakraborty, Xuan Zhao, Yu Liu, Dongyin Guan, Minh Lam, Wei Huang, Sichun Yang, Hung-Ying Kao

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Science advances · 2025
    Article
  3. Protein tyrosine phosphatase 1B is a regulator of alpha-actinin4 in the glomerular podocyte.Biochimica et biophysica acta. Molecular cell research · 2024
    Article
  4. Article
  5. Science advances · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Simran KhuranaDepartment of Biochemistry, Case Western Reserve University and the Research Institute of University Hospitals of Cleveland, Cleveland, Ohio 44106.
Sharmistha ChakrabortyDepartment of Biochemistry, Case Western Reserve University and the Research Institute of University Hospitals of Cleveland, Cleveland, Ohio 44106.
Xuan ZhaoDepartment of Biochemistry, Case Western Reserve University and the Research Institute of University Hospitals of Cleveland, Cleveland, Ohio 44106.
Yu LiuDepartment of Biochemistry, Case Western Reserve University and the Research Institute of University Hospitals of Cleveland, Cleveland, Ohio 44106.
Dongyin GuanDepartment of Biochemistry, Case Western Reserve University and the Research Institute of University Hospitals of Cleveland, Cleveland, Ohio 44106.
Minh LamComprehensive Cancer Center, Case Western Reserve University and the Research Institute of University Hospitals of Cleveland, Cleveland, Ohio 44106.
Wei HuangCenter for Proteomics and Department of Pharmacology, School of Medicine, Case Western Reserve University and the Research Institute of University Hospitals of Cleveland, Cleveland, Ohio 44106.
Sichun YangCenter for Proteomics and Department of Pharmacology, School of Medicine, Case Western Reserve University and the Research Institute of University Hospitals of Cleveland, Cleveland, Ohio 44106.
Hung-Ying KaoDepartment of Biochemistry, Case Western Reserve University and the Research Institute of University Hospitals of Cleveland, Cleveland, Ohio 44106. Electronic address: hxk43@cwru.edu.
Case Western Reserve University · USUniversity Hospitals of Cleveland · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
Alpha actinin 4: its functions and regulationR01DK078965 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI KAO, HUNG-YING · 2009 to 2013
$1.7M
Histone deacetylase 7 and its interacting proteins in endothelial cellsR01HL093269 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI KAO, HUNG-YING · 2010 to 2013
$1.5M
NCI NIH HHS P30 CA043703NCI NIH HHS P30 CA43703-12NHLBI NIH HHS HL093269NHLBI NIH HHS R01 HL093269NIDDK NIH HHS R01 DK078965NIDDK NIH HHS R01DK078965
6 · The paper itself

Abstract

α-Actinins (ACTNs) are a family of proteins cross-linking actin filaments that maintain cytoskeletal organization and cell motility. Recently, it has also become clear that ACTN4 can function in the nucleus. In this report, we found that ACTN4 (full length) and its spliced isoform ACTN4 (Iso) possess an unusual LXXLL nuclear receptor interacting motif. Both ACTN4 (full length) and ACTN4 (Iso) potentiate basal transcription activity and directly interact with estrogen receptor α, although ACTN4 (Iso) binds ERα more strongly. We have also found that both ACTN4 (full length) and ACTN4 (Iso) interact with the ligand-independent and the ligand-dependent activation domains of estrogen receptor α. Although ACTN4 (Iso) interacts efficiently with transcriptional co-activators such as p300/CBP-associated factor (PCAF) and steroid receptor co-activator 1 (SRC-1), the full length ACTN4 protein either does not or does so weakly. More importantly, the flanking sequences of the LXXLL motif are important not only for interacting with nuclear receptors but also for the association with co-activators. Taken together, we have identified a novel extended LXXLL motif that is critical for interactions with both receptors and co-activators. This motif functions more efficiently in a spliced isoform of ACTN4 than it does in the full-length protein.

Indexed as

ActininAlternative SplicingAmino Acid MotifsCell Line, TumorEstrogen Receptor alphaHumansNuclear Receptor Coactivator 1p300-CBP-Associated Factorp300-CBP Transcription FactorsProtein BindingProtein IsoformsTranscription, GeneticActininACTN4 protein, humanEstrogen Receptor alphaNuclear Receptor Coactivator 1p300-CBP-Associated Factorp300-CBP Transcription FactorsProtein Isoforms

Identifiers

PMID22908231
PMCPMC3471738
OpenAlexW1503663342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.